BioPeptics Review
A vendor displaying a named third-party lab report with a stated verification key for its retatrutide listing — offset by step-by-step reconstitution instructions on the same product page.
What we verified
We independently confirmed that biopeptics.co.za publishes a retatrutide 30mg product page priced at R2,600.00, with a repeated research-use-only disclaimer and references to third-party testing [41]. A viewable Certificate of Analysis from Janoshik, a real, named, independent peptide-testing laboratory, is displayed among the product page's own images [89]. It states a task number (#223041), a batch identifier (BIO-RETA-2608-B025), a measured result of 32.20mg retatrutide at 99.837% purity against a 30mg label, dates spanning 12–26 August 2026, and a public verification key for janoshik.com/verify/. We viewed the report image but did not run that key through Janoshik's verification portal. The Delivery Policy [90] and Returns & Refund Policy [91] are both genuinely detailed, working pages. The product page's own “Dosage Guidance” tab also displays step-by-step reconstitution instructions directly beneath its “For Research Use Only” label [41]; we do not reproduce those instructions.
What the vendor claims
BioPeptics describes retatrutide as a “next-generation triple receptor agonist peptide” targeting GLP-1, GIP and glucagon pathways, and claims its products are “independently third-party tested for identity and purity verification”, “verified for >99% purity by independent analysis” [41]. Its About page states products are “supported by clear reconstitution and usage guidelines,” and its product page's “Dosage Guidance” tab delivers on that claim directly [41].
Testing & documentation
A viewable Certificate of Analysis image is displayed among the retatrutide product page's own gallery images, issued by Janoshik — a real, named, independent peptide-testing laboratory [89]. It gives a checkable task number, a specific batch identifier, and a measured purity result, which is a materially stronger disclosure than the generic “independent analysis” language repeated elsewhere on the site. The certificate lists the sample's manufacturer as “Unknown.”
Business transparency
The Contact page lists a phone number (061 542 2136), an email address (info@biopeptics.co.za), and stated office hours (Mon–Fri, 08:00–17:00). No physical address or business registration information was found anywhere on the site.
Shipping
BioPeptics' Delivery Policy is genuinely detailed: it names two courier partners (The Courier Guy and Aramex), states orders placed before noon are processed same-day, and gives a standard delivery window of 2–5 business days within South Africa [90]. We did not independently test actual delivery performance.
Refunds & returns
The Returns & Refund Policy is genuinely detailed and loads correctly: returns are accepted only for sealed, unused items within 7 days of delivery, with replacements offered for incorrect or damaged orders reported within 48 hours [91].
Website & policies
No privacy policy or terms-of-service page could be found anywhere in BioPeptics' navigation. The top-nav “Policies” menu item is a dropdown parent with no page of its own, but its two dropdown items (Delivery Policy, Returns & Refund Policy) both load correctly and are genuinely detailed [90][91].
Public reputation
We could not locate a dedicated review-platform page for biopeptics.co.za. We are treating this as an absence of accessible evidence, not as a negative signal in itself.
Regulatory & research-use context
BioPeptics frames its products as for research use only and not intended to diagnose, treat, cure or prevent disease, consistent with retatrutide's investigational status generally (see our retatrutide research overview). Its FAQ page includes a substantive, genuinely science-literate safety-research warning about certain angiogenic peptides' potential relevance to cancer-model research — a more thorough safety disclosure than most vendors provide [92]. Set against that, the retatrutide product page's own “Dosage Guidance” tab displays step-by-step reconstitution and mixing instructions (covering reconstitution volume, handling technique, and storage conditions) directly beneath its “For Research Use Only” label [41]. No SAHPRA registration or approval is claimed.
Strengths & limitations
Strengths
- Janoshik COA displayed on the retatrutide page: batch BIO-RETA-2608-B025, 32.20mg / 99.837% purity vs a 30mg label, with a verification key
- Detailed delivery (The Courier Guy, Aramex) and returns policies
- Phone, email and office hours published
Limitations
- Product page “Dosage Guidance” tab gives step-by-step reconstitution under its “For Research Use Only” label
- No privacy policy or terms-of-service page found
- No business address or registration information is published
- No independent reputation signal (review platform) found
Evidence confidence
Medium-High. A viewable third-party Certificate of Analysis from a named, real testing laboratory (Janoshik) is directly displayed on the retatrutide product page, with a batch identifier, a specific purity/quantity result, and a public verification key — among the strongest testing evidence. Delivery and Returns & Refund policies are both genuinely detailed.
Methodology score breakdown
| Criterion | Why this score | Points |
|---|---|---|
| Business Transparency | A phone number, an email address and stated office hours are listed on the Contact page, but no address and no business registration number was found anywhere. | |
| Testing & Documentation Disclosure | A viewable Certificate of Analysis from a named laboratory (Janoshik) is displayed among the retatrutide product page's own images, with a checkable-format task number (#223041) and batch identifier (BIO-RETA-2608-B025). | |
| Independent Verifiability of Testing Claims | The Certificate of Analysis includes a stated public verification mechanism (a unique key checkable at janoshik.com/verify/); Janoshik is a real, identifiable laboratory used by other vendors. | |
| Policy Completeness (Shipping, Refunds, Terms, Privacy) | Both the Delivery Policy and the Returns & Refund Policy are genuinely detailed and load correctly, but no privacy policy or terms-of-service page exists anywhere on the site — only 2 of the 4 policy areas this criterion assesses are covered. | |
| Research-Use & Regulatory Framing Clarity | Despite a repeated “For Research Use Only” disclaimer and a substantive FAQ, the retatrutide product page's own “Dosage Guidance” tab displays step-by-step reconstitution and mixing instructions. | |
| Public Reputation Signals | No dedicated review-platform page was located for this vendor. | |
| Website & Policy Reliability | The site and its policy pages function reliably and consistently; the top-nav “Policies” menu item is a dropdown parent with no direct link of its own (a harmless, common UI pattern), and both of its dropdown items (Delivery Policy, Returns & Refund Policy) load correctly. | |
| Total | 60 / 100 | |
Sources for this review
- [41]biopeptics.co.za — Retatrutide 30mg product page (
https://biopeptics.co.za/product/retatrutide-30mg/) - [89]biopeptics.co.za (image hosted on vendor's own domain; issuing lab: Janoshik) — Janoshik Certificate of Analysis image (Task #223041, Batch BIO-RETA-2608-B025, Retatrutide 32.20mg / 99.837% purity), displayed on the retatrutide product page
- [90]biopeptics.co.za — Delivery Policy
- [91]biopeptics.co.za — Returns & Refund Policy
- [92]biopeptics.co.za — FAQ page
Editorial conclusion
The evidence supports BioPeptics as a vendor displaying a named third-party laboratory report for its retatrutide listing — a real, named lab, a checkable batch identifier, and a stated verification mechanism, among the stronger testing disclosures — and genuinely detailed, working Delivery and Returns & Refund policies. Set against that: the same product page displays step-by-step reconstitution instructions beneath its research-use disclaimer, no privacy policy or terms-of-service page exists anywhere on the site, and no business address, registration or independent reputation signal could be located. From a transparency standpoint, the displayed lab report is a meaningfully positive finding, but a reader should weigh it alongside the product page's own instructional content, which sits uneasily next to its “For Research Use Only” framing.

